Exclusive

Publication

Byline

Location

Hulic Co., Ltd. Bottom Line Advances In Nine Months

India, Oct. 28 -- Hulic Co., Ltd. (HULCF) announced a profit for its nine months that Increased, from last year The company's bottom line totaled JPY69.470 billion, or JPY91.48 per share. This compar... Read More


YURTEC Corp Bottom Line Rises In H1

India, Oct. 28 -- YURTEC Corp (1934.T) revealed a profit for its first half that Increased, from the same period last year The company's bottom line totaled JPY5.788 billion, or JPY84.26 per share. T... Read More


Hokuriku Electrical Construction Co Ltd Bottom Line Rises In H1

India, Oct. 28 -- Hokuriku Electrical Construction Co Ltd (1930.T) revealed a profit for its first half that Increased, from last year The company's bottom line came in at JPY2.293 billion, or JPY83.... Read More


Konishi Co Ltd H1 Income Advances

India, Oct. 28 -- Konishi Co Ltd (4956.T) released a profit for its first half that Increased, from the same period last year The company's earnings came in at JPY5.175 billion, or JPY83.36 per share... Read More


Matsui Securities Co. Ltd Profit Climbs In H1

India, Oct. 28 -- Matsui Securities Co. Ltd (8628.T) revealed earnings for its first half that Increased, from last year The company's earnings came in at JPY10.435 billion, or JPY40.39 per share. Th... Read More


Indian Shares Notably Lower As IT Stocks Drag

India, Oct. 28 -- Indian shares fell notably in early trade on Wednesday, with Information technology stocks coming under heavy selling pressure after an AI-fueled tech rally sent U.S. stocks to a hig... Read More


Armstrong World Industries Stock Falls 6% Despite Higher Q3 Earnings

India, Oct. 27 -- Armstrong World Industries, Inc. (AWI) is down 6.41 percent, losing $10.57 to $154.25 on Tuesday. The decline comes despite the company reporting higher third-quarter earnings, with ... Read More


Phase 2 Vs Phase 3 Clinical Trials: Why The Difference Matters Enormously For Investors?

India, Oct. 27 -- Drug development is a stepwise process, with each clinical phase answering a different question about a treatment's safety and effectiveness. In biotech investing, a "successful clin... Read More


Aclaris Therapeutics Shares Fall 3% After Announcement Of ATI-052 Study Data, Stock Offering Pricing

India, Oct. 27 -- Shares of Aclaris Therapeutics, Inc. (ACRS) are falling 3 percent on Tuesday morning after the company announced positive Phase 1b proof-of-concept results for ATI-052 and pricing of... Read More


Australian Market Pares Early Gains In Mid-market

India, Oct. 27 -- The Australian stock market is paring its early gains in mid-market moves on Wednesday, but extending the gains in the previous three sessions, with the benchmark S&P/ASX 200 moving ... Read More